CCR7 and neoplasm: Consistent with the previous understanding that tumour‐derived CCL19 inhibited the CD8 T cell and promoted lymph node metastasis,35 we hypothesize NPC tumour cells will release CCL19 and reshape the immunosuppressive TIME of metastatic lymph nodes via CCR7.